CS logo
small CS logo
ZNA Stuivenberg

Antwerpen, Belgium
Ziekenhuis in Antwerpen

About ZNA Stuivenberg


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at ZNA Stuivenberg


During the past decade, ZNA Stuivenberg conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 32 clinical trials were completed, i.e. on average, 58.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 18 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66661313111110101177112222222266554488Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "ZNA Stuivenberg" #1 sponsor was "The Lymphoma Academic Research Organisation" with 13 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 9 trials sponsored, "Amgen" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Incyte Corporation" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 50 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ZNA Stuivenberg" #1 collaborator was "Swiss Group for Clinical Cancer Research" with 3 trials as a collaborator, "Ziekenhuis Netwerk Antwerpen (ZNA)" with 3 trials as a collaborator, "AZ Sint-Jan AV" with 2 trials as a collaborator, "AZ-VUB" with 2 trials as a collaborator and "AbbVie" with 2 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 72 trials.
Created with Highcharts 11.1.0Top Leading SponsorsThe LymphomaAcademic ResearchOrganisation: 13The LymphomaAcademic ResearchOrganisation: 13Stichting Hemato-Oncologie voorVolwassenenNederland: 9Stichting Hemato-Oncologie voorVolwassenenNederland: 9Amgen: 5Amgen: 5Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Incyte Corporation: 4Incyte Corporation: 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3University of Liege: 3University of Liege: 3Bioverativ, a Sanofi company: 2Bioverativ, a Sanofi company: 2Celgene: 2Celgene: 2

Created with Highcharts 11.1.0Top CollaboratorsSwiss Group for ClinicalCancer Research: 3Swiss Group for ClinicalCancer Research: 3Ziekenhuis NetwerkAntwerpen (ZNA): 3Ziekenhuis NetwerkAntwerpen (ZNA): 3AZ Sint-Jan AV: 2AZ Sint-Jan AV: 2AZ-VUB: 2AZ-VUB: 2AbbVie: 2AbbVie: 2Archer Research: 2Archer Research: 2Cliniques universitairesSaint-Luc- UniversitéCatholique de Louvain:2Cliniques universitairesSaint-Luc- UniversitéCatholique de Louvain:2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Universiteit Antwerpen: 2Universiteit Antwerpen: 2

Clinical Trials Conditions at ZNA Stuivenberg


According to Clinical.Site data, the most researched conditions in "ZNA Stuivenberg" are "Multiple Myeloma" (12 trials), "Acute Myeloid Leukemia" (8 trials), "Follicular Lymphoma" (4 trials), "Myelodysplastic Syndromes" (4 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "ZNA Stuivenberg" in a lesser frequency.

Clinical Trials Intervention Types at ZNA Stuivenberg


Most popular intervention types in "ZNA Stuivenberg" are "Drug" (81 trials), "Other" (8 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (9 trials), "Placebo" (7 trials), "Lenalidomide" (5 trials), "placebo" (5 trials) and "Bendamustine" (4 trials). Other intervention names were less common.

Clinical Trials Genders at ZNA Stuivenberg


The vast majority of trials in "ZNA Stuivenberg" are 94 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at ZNA Stuivenberg


Currently, there are NaN active trials in "ZNA Stuivenberg". undefined are not yet recruiting, 14 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in ZNA Stuivenberg, undefined suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in ZNA Stuivenberg, 8 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 46Phase 3: 46Phase 2: 34Phase 2: 34Not Applicable: 9Not Applicable: 9Phase 1: 8Phase 1: 8Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 46Completed: 46Active, not recruiting: 22Active, not recruiting: 22Recruiting: 14Recruiting: 14Terminated: 12Terminated: 12Unknown status: 2Unknown status: 2